Senior Director, Patient Access Strategy & Operations
Takeda
Summary
The Senior Director, Patient Access Brand Strategy and Operations is responsible for developing and executing the Patient Access vision and strategy for future products in our portfolio. This role leads the design and implementation of innovative Patient Service Programs (PSPs), ensures the patient voice informs decision-making, and partners cross-functionally to optimize patient access across the product lifecycle.
Job description
This role is virtual and may sit anywhere in the continental USA with travel to Cambridge, MA a minimum of twice per month.
How you will contribute:
- Develop the Patient Access vision and strategy for Takeda portfolio drugs in alignment with BU Leadership.
- Maintain up-to-date Patient Access expertise and keep abreast of the changing external environmental factors that could affect patient access needs.
- Serve as the BU Patient Access subject matter expert and strategic partner across functions, Business Unit and Franchise Heads.
- Ensure operational success of the strategic initiatives executed by the Patient Access Team, including Hub services, copay services, free drug programs, vendor selection and management and performance management.
- Partner with senior leadership to ensure strategic initiatives are implemented across the portfolio.
- Proactively address emerging patient needs with fit-for-purpose strategic initiatives and implementation plans.
- Track and measure own team's performance against metrics and milestones.
- Serve as strategic Patient Access partner to BU and be an active member of the extended Leadership Team.
Minimum Requirements/Qualifications
- 15+ years pharmaceutical industry experience required, 5-10 years in a leadership position required.
- Significant experience in strategic and operational roles related to patient services & access.
- Experience operating in a matrix team environment.
- Strong understanding of commercial aspects of the business including brand management, sales planning and execution, market access, patient advocacy, regulatory environments and reimbursement challenges.
- Ability to leverage knowledge of marketplace and economic forces to translate long-term strategy into clear short-term plans and goals.
- Possess strong leadership, business acumen and ability to manage multiple priorities, processes, timelines and expectations of multiple stakeholder groups.
- Ability to refine team strategy based on anticipated future changes.
- A demonstrated ability to process complex information and summarize it concisely in writing and/or verbally in a professional manner and in a time sensitive environment is required.
- Demonstrated success in development/execution of targeted briefings for executive leadership, senior management and business leaders.
- Proven skills as an effective team player who can engender credibility and confidence within and outside the company.
- Embraces and demonstrates a diversity and inclusion mindset and role models these behaviors for the organization.
- Ability to lead, manage and motivate teams, with or without direct supervisory authority.
- Experience in managing projects, including overseeing work plans, budgets.
Travel Requirements: Ability and willingness to travel as needed to home office & to various meetings and vendor sites; including overnight trips.
Requirements
- 15+ years pharmaceutical industry experience required
- 5-10 years in a leadership position required
- Significant experience in strategic and operational roles related to patient services & access
- Experience operating in a matrix team environment
- Strong understanding of commercial aspects including brand management, sales planning and execution, market access, patient advocacy, regulatory environments and reimbursement challenges
- Ability to leverage knowledge of marketplace and economic forces to translate long-term strategy into clear short-term plans and goals
- Strong leadership and business acumen
- Ability to manage multiple priorities, processes, timelines and expectations of multiple stakeholder groups
- Ability to refine team strategy based on anticipated future changes
- Demonstrated ability to process complex information and summarize it concisely in writing and/or verbally
- Demonstrated success in development/execution of targeted briefings for executive leadership, senior management and business leaders
- Well organized, highly motivated, innovative, process driven, results oriented
- Outstanding oral and written communications skills
- Proven skills as an effective team player who can engender credibility and confidence
- Embraces and demonstrates a diversity and inclusion mindset
- Ability to lead, manage and motivate teams, with or without direct supervisory authority
- Experience in managing projects, including overseeing work plans, budgets
- Ability and willingness to travel as needed
Company overview
Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company founded in 1781 and incorporated in 1925. As one of the world's top 20 largest pharmaceutical companies by revenue and the third largest in Asia, Takeda specializes in developing and commercializing innovative medicines across several therapeutic areas including oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies, and vaccines. With approximately 49,095 employees globally, the company operates research and development centers, manufacturing facilities, and commercial operations across 39 U.S. states and numerous countries worldwide. Takeda maintains dual headquarters in Tokyo and Osaka, Japan, with significant operations in Cambridge, Massachusetts, where it serves as the largest life sciences employer in the state. The company's patient-focused approach is guided by its Takeda-ism values of Integrity, Fairness, Honesty, and Perseverance, emphasizing a commitment to delivering life-transforming treatments while advancing sustainable healthcare solutions. Takeda's extensive portfolio includes both innovative biologics and small molecule drugs, supported by strategic acquisitions and partnerships that have expanded its capabilities in areas such as immuno-oncology and rare disease treatments.